Effectiveness, satisfaction and compliance with imiquimod in the treatment of external anogenital warts

International Journal of STD and AIDS

Volumn 14, Issue 1, 2003, Pages 11-17

  Vilata, Juan José ^a   Badia, Xavier ^b,c   Aguanell, M V ^d   Albero, F ^d   Albert, A ^d   Alonso, J ^d   Alsina, C ^d   Arguisjuela, M T ^d   Asin ^d   Balaguer, J ^d   Ballesteros, J ^d   Banuls N ^d   Bassem, Ali ^d   Bilbao, B ^d   Borbujo, J ^d   Boronat, J ^d   Bou, D ^d   Camara, M ^d   Cararach, M ^d   Carrillo, B ^d   Casasus A ^d   Castells, A ^d   Castizo, A ^d   Castro, M ^d   Cavalle P ^d   Centeno, C ^d   Colombo, J A ^d   Colomo, C ^d   Curto, J R ^d   Del Solar, J M ^d   De Unamuno, P ^d   Diez, ^d   Duran M ^d   Egea, J ^d   Farina M ^d   Fernandez Vozmediano J M ^d   Fonseca, E ^d   Formigon M ^d   Frias, I ^d   Fuste P ^d   Garcia Font M ^d   Garcia Iglesias A ^d   Garcia Marques J M ^d   Garcia Rodriguez M ^d   Garzon Sanchez J M ^d   Gayete Martinez J ^d   Gimeno, E ^d   Gonzalez Martin A ^d   Gonzalez Mirasol E ^d   Grau, C ^d   Hergueta, P ^d   Hernandez Torres F ^d   Herranz, P ^d   Jamal, S ^d   Jo Chu, J ^d   Jorda, E ^d   Landa, N ^d   Llamas, R ^d   Llistosella, Ll ^d   Lepe, I ^d   Lopez Salva A ^d   Marquina, A ^d   Martinez Jorda E ^d   Miralles, J ^d   Miranda, A ^d   Moreno, S ^d   Morinigos J I ^d   Munoz J ^d   Mut, J ^d   Navas, J ^d   Navarro, V ^d   Nieto, I ^d   Numancia, B ^d   Nwelati, M ^d   Ojeda, A ^d   Olmos, L ^d   Ortiz, F ^d   Pagerols, ^d   Palomeque, F ^d   Perea, M ^d   Perulero, N ^d   Pueyo, I ^d   Puig, L M ^d   Quilez M ^d   Reyes, M J ^d   Rementeria, ^d   Rios L ^d   Rodriguez Cerdeira C ^d   Rodriguez Garcia J R ^d   Rodriguez Prieto M ^d   Roset, M ^d   Rubio, D ^d   Saben, M ^d   Salvatella, N ^d   Sainz De Los Terreros, M ^d   Sanz, B ^d   Sanchez Hernandez M ^d   Sanchez Porro J L ^d   Saran M T ^d   more..

^a HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c Health Outcomes Research Europe   (Spain)

^d Hosp Gen Universitario de Valencia ^*

Author keywords

Compliance; Effectiveness; External anogenital warts; Imiquimod; Satisfaction

Indexed keywords

IMIQUIMOD;

ADULT; AGED; ANUS; ARTICLE; BURNING SENSATION; CLINICAL PRACTICE; CLINICAL TRIAL; COHORT ANALYSIS; CONDYLOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EDEMA; EROSION; ERYTHEMA; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATION; PAIN; PATIENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; TREATMENT OUTCOME; ULCER;

ADULT; AMINOQUINOLINES; CONDYLOMATA ACUMINATA; HUMANS; INTERFERON INDUCERS; MALE; OINTMENTS; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VAGINAL CREAMS, FOAMS, AND JELLIES;

EID: 0037238986     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646203321043192     Document Type: Article

References (28)

1. Strauss MJ, Khanna V, Koenig JD, et al. The cost of treating genital warts. Int J Dermatol 1996;35:340-8
2. Kraus SJ, Stone KM. Management of genital infection caused by human papillomavirus. Rev Infect Dis 1990;12(Suppl 6):S620-32
3. Syrjänen K, Syrjänen S. Epidemiology of human papiloma-virus infections and genital neoplasia. Scand J Infect Dis Suppl 1990;60:7-17
4. Syrjänen KJ. Long term consequences of genital HPV infections in women. Ann Med 1992;24:233-45
5. Chuang T-Y, Perry HO, Kurland LT, et al. Condyloma acuminatum in Rochester, Minn, 1950-1978. Epidemiology and clinical features. Arch Dermatol 1984;120:469-75
6. Von Krogh G, Lancey CJN, Gross G, Barrasso R, Schneider A. European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts. Sex Transm Infect 2000;76:162-8
7. Maw RD, Reitano M, Roy M. An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle. Int J STD AIDS 1998;9:517-8
8. Beutner KR, Ferenczy A. Therapeutic approaches to genital wards. Am J Med 1997;102:28-37
9. Moore RA, Edwards JE, Hopwood J, Hicks D. Imiquimod for the treatment of genital warts: a quantitative systematic review. Bio Med Central Infect Dis 2001;1:3-9
10. Gollnick H, Barasso R, Jappe U, et al. Safety and efficacy of imiquimod 5% cream in the treatment penile genital warts in uncircumcised men when applied three times weekly or once per day. Int J STD AIDS 2001;12:22-8
11. O'Mahony C, Law C, Gollnuck HPM, Marini M. New patients - applied therapy for anogenital wards is rated favourably by patients. Int J STD AIDS 2001;12:565-70
12. Herdman M, Badia X. La medida de la satisfacción con el tratamiento en la investigación de resultados en salud. In: Badia X, ed. La investigación de Resultados en Salud. Barcelona: Edimac, 2000:79-90
13. Lochman JE. Factors related to patients' satisfaction with their medical care. J Comm Health 1983;991-108
14. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74
15. Edwards L, Ferency A, Eron L, et al. Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 1998;134:25-30
16. Beutner KR, Spruance SL, Hougham AJ, Fox TL, Owens ML, Douglas JM. Treatment of genital warts with an immune response modifier (imiquimod). J Am Acad Dermatol 1998;38:230-9
17. Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ 1996;312:1215-21
18. Fife KH, Ferenczy A, Douglas JM, Brown DR, Smith M, Owens M, The HPV Study Group. Treatment of external genital warts in men using 5% Imiquimod cream applied three times a week, once daily, twice daily, or three times a day. Sex Transm Dis 2001;28:226-31
19. Beutner KR, Tyring SK, Trofatter KH, et al. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts. Antimicrob Agents Chemother 1998;42:789-94
20. Garland SM, Sellors JW, Wikstrom A, Petersen CS, Aranda C, Arac S, Maw RD, Imiquimod Study Group. Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts - results of an open-label, multicentre Phase IIIB trial. Int J STD AIDS 2001;12:722-9
21. Hengge UR, Schulterwolter T, Behrendt C, Meyer T, Stockfle R, Goos M. Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol 2000;143:1026-31
22. Nelson AL. The importance of patient and health care provider perception in the evaluation of imiquimod and other prior treatments for anogenital warts. Int J STD AIDS 2002;13:29-35
23. Sverrisson T, Gross R, Pearson J, Rusk C, Adamsos I. The dorzolamide/timodol combination versus timodol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group. J Glaucoma 1999;8:315-24
24. De la Taille A, Delmas V, Amar E, Boccon-Gibod L. Reasons of dropout from short- and long-term self-injection therapy for impotence. Eur Urol 1999;35:312-17
25. Shen W, Kotsanos JG, Huster WJ, Mathias SD, Andrejasich CM, Patrick DL. Development and validation of the Diabetes Quality of Life Clinical Trial Questionnaire. Med Care 1999;37(Suppl 4):AS45-66
26. Shiklar R, Halpern M, McGann M, Palmer CS, Seidlin M. The relation of patient satisfaction with treatment of otitis externa to clinical outcomes: development of an instrument. Clin Ther 1999;21:1091-104
27. Ries RK, Jaffe C, Comtois KA, Kitchell M. Treatment satisfaction compared with outcome in severe dual disorders. Commun Ment Health J 1999;35:213-21
28. McClean H, Weaver S. Information given to patients with genital warts at a genitourinary medicine clinic: a baseline assessment. Int J STD AIDS 2002;13:223-9